de Bruijn M A, Noordam C, Goldhoorn B G, Tytgat G N, Groen A K
Division of Gastrointestinal and Liver Diseases, Academic Medical Centre, Amsterdam, The Netherlands.
Biochim Biophys Acta. 1992 Jan 16;1138(1):41-5. doi: 10.1016/0925-4439(92)90149-h.
The validity of the cholesterol nucleation assay rests on the assumption that all cholesterol crystals are removed at the start of the assay so that de novo formation of crystals can be studied. In this paper we have tested the validity of this assumption. Cholesterol crystals were added to supersaturated model bile. Subsequently the mixtures were either filtered over a 0.22 micron filter or centrifuged at 37 degrees C for 2 h at 100,000 x g. After ultracentrifugation the isotropic interphase was collected. Using polarized light microscopy no crystals could be visualized in this fraction. However, the nucleation time of the isotropic interphase decreased from 6.8 +/- 1.1 days to 1.8 +/- 0.2 days (mean +/- S.E., P less than 0.01, n = 5) when 10-100 micrograms/ml crystals were added prior to centrifugation. Similar results were observed when instead of centrifugation the mixtures containing crystals were filtered. After filtration over a 0.22 micron filter no crystals could be detected in the filtrate. Yet the nucleation time of the filtrate decreased from 6.4 +/- 0.7 days to 3.1 +/- 0.5 days (mean +/- S.E.) when 10 micrograms/ml cholesterol crystals were added before filtration (n = 10, P less than 0.01). Since no cholesterol crystals could be detected at the start of the assay the reduction in nucleation time must have been brought about by cholesterol microcrystals that passed through the filter. Supplementation of cholesterol crystals to model bile did not accelerate the nucleation time when the samples were passed over a 0.02 micron filter, indicating that the size of the microcrystals was larger than 20 nm. The effect of addition of cholesterol crystals prior to filtration over a 0.22 micron filter was also tested in the crystal growth assay recently developed by Busch et al. ((1990) J. Lipid Res. 31, 1903-1909). Addition of crystals had only a minor effect on the assay. In conclusion, the reduced nucleation time of biles from gallstone patients is probably not only due to the presence of promoting or the absence of inhibiting proteins, but can be caused by the presence of small cholesterol crystals in these biles.
胆固醇成核试验的有效性基于这样一个假设,即在试验开始时所有胆固醇晶体都已被去除,以便能够研究晶体的从头形成。在本文中,我们对这一假设的有效性进行了测试。将胆固醇晶体添加到过饱和的模型胆汁中。随后,将混合物要么通过0.22微米滤膜过滤,要么在37℃下以100,000×g离心2小时。超速离心后,收集各向同性中间相。使用偏光显微镜在此部分中未观察到晶体。然而,当在离心前添加10 - 100微克/毫升的晶体时,各向同性中间相的成核时间从6.8±1.1天降至1.8±0.2天(平均值±标准误,P<0.01,n = 5)。当对含有晶体的混合物进行过滤而非离心时,观察到了类似结果。通过0.22微米滤膜过滤后,滤液中未检测到晶体。然而,当在过滤前添加10微克/毫升胆固醇晶体时,滤液的成核时间从6.4±0.7天降至3.1±0.5天(平均值±标准误)(n = 10,P<0.01)。由于在试验开始时未检测到胆固醇晶体,成核时间的缩短必定是由通过滤膜的胆固醇微晶引起的。当样品通过0.02微米滤膜时,向模型胆汁中补充胆固醇晶体并未加速成核时间,这表明微晶的尺寸大于20纳米。在Busch等人最近开发的晶体生长试验中((1990年)《脂质研究杂志》31卷,1903 - 1909页),也测试了在通过0.22微米滤膜过滤前添加胆固醇晶体的效果。添加晶体对该试验仅有轻微影响。总之,胆结石患者胆汁成核时间缩短可能不仅是由于存在促进蛋白或不存在抑制蛋白,还可能是由于这些胆汁中存在小的胆固醇晶体。